Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Krailo

Showing results (51-60 of 161) with videos related to

Pageof 17
Sort By:
Cancer Epidemiology|January 15, 2013
Maternal pregnancy events and exposures and risk of hepatoblastoma: a Children's Oncology Group (COG) studyJessica R B Musselman, Michael K Georgieff, Julie A Ross, et al.
Cancer|August 4, 2005
Phase 1 study of concurrent RMP-7 and carboplatin with radiotherapy for children with newly diagnosed brainstem gliomasRoger J Packer, Mark Krailo, Minesh Mehta, et al.
Cancer|September 24, 2005
A Phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomasRoger J Packer, Mark Krailo, Minesh Mehta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2004
Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children's Oncology Group study (ADVL0015)Susan M Blaney, Mark Bernstein, Kathleen Neville, et al.
Cancer Research|May 20, 2016
p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in OsteosarcomaYiting Li, Manjula Nakka, Aaron J Kelly, et al.
Ophthalmology|June 6, 2016
Correlation of Insurance, Race, and Ethnicity with Pathologic Risk in a Controlled Retinoblastoma Cohort: A Children's Oncology Group StudyAdam L Green, Murali Chintagumpala, Mark Krailo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2007
Multiple drug resistance in osteogenic sarcoma: INT0133 from the Children's Oncology GroupCindy L Schwartz, Richard Gorlick, Lisa Teot, et al.
European Journal of Cancer (Oxford, England : 1990)|November 18, 2011
A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children's Oncology GroupSylvain Baruchel, Alberto Pappo, Mark Krailo, et al.
Cancer|October 7, 2018
Klinefelter syndrome in males with germ cell tumors: A report from the Children's Oncology GroupLindsay A Williams, Nathan Pankratz, John Lane, et al.
Blood|July 3, 2004
Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 studyMartin A Champagne, Renaud Capdeville, Mark Krailo, et al.
Pageof 17

Showing results (51-60 of 161) with videos related to

Sort By:
Pageof 17
Cancer Epidemiology|January 15, 2013
Maternal pregnancy events and exposures and risk of hepatoblastoma: a Children's Oncology Group (COG) studyJessica R B Musselman, Michael K Georgieff, Julie A Ross, et al.
Cancer|August 4, 2005
Phase 1 study of concurrent RMP-7 and carboplatin with radiotherapy for children with newly diagnosed brainstem gliomasRoger J Packer, Mark Krailo, Minesh Mehta, et al.
Cancer|September 24, 2005
A Phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomasRoger J Packer, Mark Krailo, Minesh Mehta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2004
Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children's Oncology Group study (ADVL0015)Susan M Blaney, Mark Bernstein, Kathleen Neville, et al.
Cancer Research|May 20, 2016
p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in OsteosarcomaYiting Li, Manjula Nakka, Aaron J Kelly, et al.
Ophthalmology|June 6, 2016
Correlation of Insurance, Race, and Ethnicity with Pathologic Risk in a Controlled Retinoblastoma Cohort: A Children's Oncology Group StudyAdam L Green, Murali Chintagumpala, Mark Krailo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2007
Multiple drug resistance in osteogenic sarcoma: INT0133 from the Children's Oncology GroupCindy L Schwartz, Richard Gorlick, Lisa Teot, et al.
European Journal of Cancer (Oxford, England : 1990)|November 18, 2011
A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children's Oncology GroupSylvain Baruchel, Alberto Pappo, Mark Krailo, et al.
Cancer|October 7, 2018
Klinefelter syndrome in males with germ cell tumors: A report from the Children's Oncology GroupLindsay A Williams, Nathan Pankratz, John Lane, et al.
Blood|July 3, 2004
Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 studyMartin A Champagne, Renaud Capdeville, Mark Krailo, et al.
Pageof 17